Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)

v3.21.1
Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Series A Preferred Stock [Member]
Series B Preferred Stock [Member]
Common Stock [Member]
Common Stock Issuable [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income [Member]
Treasury Stock [Member]
Total
Balance at Jun. 30, 2019 $ 5,000 $ 1 $ 45,714,289 $ (51,041,047) $ 1,066,998 $ (46,477) $ (4,301,236)
Balance, shares at Jun. 30, 2019 500,000 1 968          
Issuance of common stock for conversion of convertible debt and accrued interest 123,713 123,713
Issuance of common stock for conversion of convertible debt and accrued interest, shares 182          
Reclassification of put premium upon debt conversion 73,235 73,235
Relative fair value of warrants issued with convertible debt 375,905 375,905
Issuance of common stock for services 39,800 39,800
Issuance of common stock for services, shares 20          
Stock based compensation in connection with stock option grants and restricted stock unit grants 75,104 75,104
Foreign currency translation gain/loss 563,687 563,687
Net loss (1,491,940) (1,491,940)
Balance at Sep. 30, 2019 $ 5,000 $ 1 46,402,046 (52,532,987) 1,630,685 (46,477) (4,541,732)
Balance, shares at Sep. 30, 2019 500,000 1 1,170          
Balance at Jun. 30, 2019 $ 5,000 $ 1 45,714,289 (51,041,047) 1,066,998 (46,477) (4,301,236)
Balance, shares at Jun. 30, 2019 500,000 1 968          
Net loss                 (5,944,711)
Balance at Mar. 31, 2020 $ 5,000 $ 18,481 48,879,086 (56,985,758) 3,282,760 (46,477) (4,846,908)
Balance, shares at Mar. 31, 2020 500,000 1 18,481,410          
Balance at Sep. 30, 2019 $ 5,000 $ 1 46,402,046 (52,532,987) 1,630,685 (46,477) (4,541,732)
Balance, shares at Sep. 30, 2019 500,000 1 1,170          
Issuance of common stock for conversion of convertible debt and accrued interest $ 1 219,465 219,466
Issuance of common stock for conversion of convertible debt and accrued interest, shares 1,065          
Reclassification of put premium upon debt conversion 86,970 86,970
Stock based compensation in connection with stock option grants and restricted stock unit grants 75,104 75,104
Stock based compensation in connection with fair value of warrants issued for services 984,810 984,810
Foreign currency translation gain/loss (629,494) (629,494)
Net loss (1,867,109) (1,867,109)
Balance at Dec. 31, 2019 $ 5,000 $ 2,235 47,768,395 (54,400,096) 1,001,191 (46,477) (5,671,985)
Balance, shares at Dec. 31, 2019 500,000 1 2,234,901          
Issuance of common stock for conversion of convertible debt and accrued interest $ 16,096   793,989 810,085
Issuance of common stock for conversion of convertible debt and accrued interest, shares 16,096,509            
Reclassification of put premium upon debt conversion   222,981 222,981
Issuance of common stock for services $ 150   20,850 21,000
Issuance of common stock for services, shares 150,000            
Stock based compensation in connection with stock option grants and restricted stock unit grants   75,104 75,104
Foreign currency translation gain/loss   2,281,569 2,281,569
Net loss (2,585,662) (2,585,662)
Balance at Mar. 31, 2020 $ 5,000 $ 18,481 48,879,086 (56,985,758) 3,282,760 (46,477) (4,846,908)
Balance, shares at Mar. 31, 2020 500,000 1 18,481,410          
Balance at Jun. 30, 2020     $ 258 50,913,893 (55,781,770) 1,267,671 (46,477) (3,641,425)
Balance, shares at Jun. 30, 2020 500,000 1 258,120          
Issuance of common stock for conversion of convertible debt and accrued interest $ 442 480,133 480,575
Issuance of common stock for conversion of convertible debt and accrued interest, shares 442,031            
Reclassification of put premium upon debt conversion 204,919 204,919
Foreign currency translation gain/loss (75,755) (75,755)
Issuance of common stock for exercise of warrants $ 15 201,029 201,044
Issuance of common stock for exercise of warrants, shares 15,445          
Stock based compensation in connection with stock option grants 20,718 20,718
Net loss (425,545) (425,545)
Balance at Sep. 30, 2020 $ 5,000 $ 715 51,820,692 (56,207,315) 1,191,916 (46,477) (3,235,469)
Balance, shares at Sep. 30, 2020 500,000 1 715,596          
Balance at Jun. 30, 2020     $ 258 50,913,893 (55,781,770) 1,267,671 (46,477) (3,641,425)
Balance, shares at Jun. 30, 2020 500,000 1 258,120          
Net loss                 (1,246,926)
Balance at Mar. 31, 2021     $ 4,969 $ 130 53,007,522 (57,028,696) 1,053,874 (46,477) (3,003,678)
Balance, shares at Mar. 31, 2021 500,000 1 4,968,824 130,098          
Balance at Sep. 30, 2020 $ 5,000 $ 715 51,820,692 (56,207,315) 1,191,916 (46,477) (3,235,469)
Balance, shares at Sep. 30, 2020 500,000 1 715,596          
Issuance of common stock for conversion of convertible debt and accrued interest $ 703 141,126 141,829
Issuance of common stock for conversion of convertible debt and accrued interest, shares 702,623          
Reversal of common stock issuable due to cancellation of conversions of convertible debt and accrued interest $ (24) (19,992) (20,016)
Reversal of common stock issuable due to cancellation of conversions of convertible debt and accrued interest, shares (24,427)          
Reversal of put premium upon cancellation of conversions of convertible debt (11,785) (11,785)
Reclassification of put premium upon debt conversion 68,090 68,090
Foreign currency translation gain/loss (167,765) (167,765)
Fractional difference due to the reverse stock-split
Fractional difference due to the reverse stock-split, shares 142            
Issuance of common stock for exercise of warrants $ 53 $ 147 (200)
Issuance of common stock for exercise of warrants, shares 52,900 147,099          
Stock based compensation in connection with stock option grants 20,718 20,718
Vested restricted stock units
Vested restricted stock units, shares 59          
Net loss (403,643) (403,643)
Balance at Dec. 31, 2020 $ 5,000 $ 1,447 $ 147 52,018,649 (56,610,958) 1,024,151 (46,477) (3,608,041)
Balance, shares at Dec. 31, 2020 500,000 1 1,446,834 147,158          
Issuance of common stock for conversion of convertible debt and accrued interest $ 2,342 $ 130 389,328 391,800
Issuance of common stock for conversion of convertible debt and accrued interest, shares 2,341,733 130,039          
Reclassification of put premium upon debt conversion 187,349 187,349
Issuance of common stock for cashless exercise of warrants $ 947 $ (147) (800)
Issuance of common stock for cashless exercise of warrants, shares 947,095 (147,099)          
Issuance of common stock for services $ 225 67,286 67,511
Issuance of common stock for services, shares 225,037          
Stock based compensation in connection with stock option grants and restricted stock unit grants 20,718 20,718
Foreign currency translation gain/loss 29,723 29,723
Issuance of common stock for exercise of warrants $ 8 324,992 325,000
Issuance of common stock for exercise of warrants, shares 8,125          
Net loss (417,738) (417,738)
Balance at Mar. 31, 2021     $ 4,969 $ 130 $ 53,007,522 $ (57,028,696) $ 1,053,874 $ (46,477) $ (3,003,678)
Balance, shares at Mar. 31, 2021 500,000 1 4,968,824 130,098